UNSPSC 41202042: Neisseria spp. direct serological test reagents

In this classification, Neisseria genus direct serological test reagents are devices used in test to identify specific Neisseria genus direct serological test reagents antibodies in serum. US FDA regulates Neisseria genus direct serological test reagents under 21 CFR 866.3390 and under FDA product code LIR.

UNSPSC 41202042 Neisseria spp. direct serological test reagents (Commodity) covers diagnostic test kits and reagents for detection of Neisseria gonorrhoeae and related sexually transmitted infections in clinical laboratory settings. State and local governments procure these products through public health departments, county health agencies, and corrections departments operating clinical or point-of-care testing programs. Recent solicitations show demand for both nucleic acid amplification test (NAAT) kits compatible with manufacturer-specific analyzer platforms and immunoassay-based reagent systems, often bundled with calibrators, controls, collection devices, and consumables required to maintain operational compliance with CLIA certification and laboratory quality-control standards. Issuing bodies include state departments of public health (notably Illinois), county health care services and corrections departments (Collin County, Texas; Gwinnett County, Georgia), and municipal public health programs (City of Austin). Contracts typically extend one to five years with optional renewal periods and are structured on annual or per-test pricing models to accommodate variable testing volumes driven by population health surveillance demand and criminal justice screening requirements.

Illinois Department of Public Health has posted the most recent activity, with a change order (IFB, response due October 13, 2026) for Hologic NG/NT testing kits increasing annual volume from 15,000 to 25,000 tests and from 15,000 to 30,000 collection kits under a five-year reagent rental agreement at the Carbondale Laboratory, and a prior emergency sole-source procurement from Abbott Laboratories for HIV/Syphilis reagents valued at $38,079.50. Collin County, Texas issued an RFP (due July 23, 2026) for offender specimen collection and drug testing services encompassing approximately 25,031 annual tests with estimated annual value of $600,000. The City of Austin conducted dual HIV test kit procurements (IFB, July 17, 2026 and rebid September 3, 2026) for Abbott Determine rapid test kits at approximately 375 units annually. Gwinnett County, Georgia posted an RFP (due October 14, 2026) for drug testing supplies compatible with an existing analyzer, with limited scope detail available. Recent solicitations are concentrated in Texas and Illinois, with activity spanning public health disease surveillance, corrections offender screening, and municipal rapid testing programs.